215 related articles for article (PubMed ID: 26246099)
1. MR spectroscopy of intracranial tuberculomas: A singlet peak at 3.8 ppm as potential marker to differentiate them from malignant tumors.
Morales H; Alfaro D; Martinot C; Fayed N; Gaskill-Shipley M
Neuroradiol J; 2015 Jun; 28(3):294-302. PubMed ID: 26246099
[TBL] [Abstract][Full Text] [Related]
2. Differentiation of intracranial tuberculomas and high grade gliomas using proton MR spectroscopy and diffusion MR imaging.
Peng J; Ouyang Y; Fang WD; Luo TY; Li YM; Lv FJ; Zhang ZW; Li XY
Eur J Radiol; 2012 Dec; 81(12):4057-63. PubMed ID: 22749802
[TBL] [Abstract][Full Text] [Related]
3. Combination of single-voxel proton MR spectroscopy and apparent diffusion coefficient calculation in the evaluation of common brain tumors.
Bulakbasi N; Kocaoglu M; Ors F; Tayfun C; Uçöz T
AJNR Am J Neuroradiol; 2003 Feb; 24(2):225-33. PubMed ID: 12591638
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of intracranial tuberculomas using diffusion-weighted imaging (DWI), magnetic resonance spectroscopy (MRS) and susceptibility weighted imaging (SWI).
Parry AH; Wani AH; Shaheen FA; Wani AA; Feroz I; Ilyas M
Br J Radiol; 2018 Nov; 91(1091):20180342. PubMed ID: 29987985
[TBL] [Abstract][Full Text] [Related]
5. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
[TBL] [Abstract][Full Text] [Related]
6. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
[TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance spectroscopy detection of high lipid levels in intraaxial tumors without central necrosis: a characteristic of malignant lymphoma.
Yamasaki F; Takayasu T; Nosaka R; Amatya VJ; Doskaliyev A; Akiyama Y; Tominaga A; Takeshima Y; Sugiyama K; Kurisu K
J Neurosurg; 2015 Jun; 122(6):1370-9. PubMed ID: 25748300
[TBL] [Abstract][Full Text] [Related]
8. Metabolic mapping of gliomas using hybrid MR-PET imaging: feasibility of the method and spatial distribution of metabolic changes.
Bisdas S; Ritz R; Bender B; Braun C; Pfannenberg C; Reimold M; Naegele T; Ernemann U
Invest Radiol; 2013 May; 48(5):295-301. PubMed ID: 23296081
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic assessment of brain tumours and non-neoplastic brain disorders in vivo using proton nuclear magnetic resonance spectroscopy and artificial neural networks.
Poptani H; Kaartinen J; Gupta RK; Niemitz M; Hiltunen Y; Kauppinen RA
J Cancer Res Clin Oncol; 1999; 125(6):343-9. PubMed ID: 10363566
[TBL] [Abstract][Full Text] [Related]
10. Cutoff value of choline concentration reliably reveals high-grade brain tumors among other contrast-enhancing brain lesions.
Porto L; Hattingen E; Stuecher A; Herminghaus S; Lanfermann H; Ulrich Pilatus UP
J Neurol Surg A Cent Eur Neurosurg; 2012 May; 73(3):147-52. PubMed ID: 22190143
[TBL] [Abstract][Full Text] [Related]
11. In vivo single-voxel proton MR spectroscopy in the differentiation of high-grade gliomas and solitary metastases.
Fan G; Sun B; Wu Z; Guo Q; Guo Y
Clin Radiol; 2004 Jan; 59(1):77-85. PubMed ID: 14697379
[TBL] [Abstract][Full Text] [Related]
12. Comparison of 3 Tesla proton MR spectroscopy, MR perfusion and MR diffusion for distinguishing glioma recurrence from posttreatment effects.
Fink JR; Carr RB; Matsusue E; Iyer RS; Rockhill JK; Haynor DR; Maravilla KR
J Magn Reson Imaging; 2012 Jan; 35(1):56-63. PubMed ID: 22002882
[TBL] [Abstract][Full Text] [Related]
13. Preliminary study of 3T 1H MR spectroscopy in bone and soft tissue tumors.
Qi ZH; Li CF; Li ZF; Zhang K; Wang Q; Yu DX
Chin Med J (Engl); 2009 Jan; 122(1):39-43. PubMed ID: 19187615
[TBL] [Abstract][Full Text] [Related]
14. Comparative evaluation of magnetization transfer MR imaging and in-vivo proton MR spectroscopy in brain tuberculomas.
Gupta RK; Husain M; Vatsal DK; Kumar R; Chawla S; Husain N
Magn Reson Imaging; 2002 Jun; 20(5):375-81. PubMed ID: 12206861
[TBL] [Abstract][Full Text] [Related]
15. Recognition of anaplastic foci within low-grade gliomas using MR spectroscopy.
Bradac O; Vrana J; Jiru F; Kramar F; Netuka D; Hrabal P; Horinek D; de Lacy P; Benes V
Br J Neurosurg; 2014 Oct; 28(5):631-6. PubMed ID: 24377726
[TBL] [Abstract][Full Text] [Related]
16. In the assessment of supratentorial glioma grade: the combined role of multivoxel proton MR spectroscopy and diffusion tensor imaging.
Zou QG; Xu HB; Liu F; Guo W; Kong XC; Wu Y
Clin Radiol; 2011 Oct; 66(10):953-60. PubMed ID: 21663899
[TBL] [Abstract][Full Text] [Related]
17. Study of single voxel 1H MR spectroscopy of bone tumors: differentiation of benign from malignant tumors.
Zhang J; Cheng K; Ding Y; Liang W; Ding Y; Vanel D; Cheng X
Eur J Radiol; 2013 Dec; 82(12):2124-8. PubMed ID: 22169357
[TBL] [Abstract][Full Text] [Related]
18. MR spectroscopy using normalized and non-normalized metabolite ratios for differentiating recurrent brain tumor from radiation injury.
Elias AE; Carlos RC; Smith EA; Frechtling D; George B; Maly P; Sundgren PC
Acad Radiol; 2011 Sep; 18(9):1101-8. PubMed ID: 21820634
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of proton magnetic resonance spectroscopy in the noninvasive grading of solid gliomas: comparison of maximum and mean choline values.
Senft C; Hattingen E; Pilatus U; Franz K; Schänzer A; Lanfermann H; Seifert V; Gasser T
Neurosurgery; 2009 Nov; 65(5):908-13; discussion 913. PubMed ID: 19834403
[TBL] [Abstract][Full Text] [Related]
20. Proton magnetic resonance spectroscopic imaging to differentiate between nonneoplastic lesions and brain tumors in children.
Hourani R; Horská A; Albayram S; Brant LJ; Melhem E; Cohen KJ; Burger PC; Weingart JD; Carson B; Wharam MD; Barker PB
J Magn Reson Imaging; 2006 Feb; 23(2):99-107. PubMed ID: 16374884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]